HUM : Summary for Humana Inc. Common Stock - Yahoo Finance

U.S. Markets open in 5 hrs 16 mins

Humana Inc. (HUM)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
208.83-4.80 (-2.25%)
At close: 4:02 PM EST
People also watch:
CIAETUNHMCKHCA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close213.63
Open214.00
Bid208.34 x 500
Ask208.39 x 500
Day's Range204.71 - 214.87
52 Week Range150.00 - 217.80
Volume2,847,161
Avg. Volume1,253,841
Market Cap31.14B
Beta0.99
PE Ratio (TTM)28.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.16 (0.54%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal4 hours ago

    [$$] Aetna and Humana Defend Merger, as Antitrust Trial Begins

    The Justice Department and proposed merger partners Aetna Inc. and Humana Inc. presented a judge Monday with starkly different visions of how the transaction would affect the marketplace.

  • Reuters10 hours ago

    U.S. attorneys argue Aetna-Humana deal violates antitrust law

    A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking off a trial expected to last weeks. The Justice Department filed a lawsuit in July asking the court to stop Aetna's $34 billion deal for Humana, arguing it would lead to higher prices for seniors and the disabled on Medicare and for people who use the individual insurance program created under the Affordable Care Act, popularly known as Obamacare. Aetna defended the deal on Monday, arguing that Medicare Advantage competes with the government's traditional Medicare program for elderly or disabled patients.

  • Investopedia11 hours ago

    Trial Begins in DoJ Bid to Block Aetna/Humana Merger (AET, HUM)

    Opening arguments began today in the antitrust suit to block Aetna's $34 billion acquisition of Humana.